Evidence map›Paper›PMID 34610340›Full record

ArticleJournal of molecular and cellular cardiology2022

Conditional depletion of the acetyltransferase Tip60 protects against the damaging effects of myocardial infarction.

Xinrui Wang, Tina C Wan, Amelia Lauth, Alexandra L Purdy, Katherine R Kulik, Michaela Patterson, John W Lough, John A Auchampach

Open access · greenAbstract read
In one paragraph

Article in Journal of molecular and cellular cardiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Acetyltransferase in cardiovascular disease and aging.The journal of cardiovascular aging · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Measuring cardiomyocyte cell-cycle activity and proliferation in the age of heart regeneration.American journal of physiology. Heart and circulatory physiology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Xinrui WangDepartment of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI, USA; Cardiovascular Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Tina C WanDepartment of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI, USA; Cardiovascular Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Amelia LauthDepartment of Cell Biology Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, WI, USA; Cardiovascular Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Alexandra L PurdyDepartment of Cell Biology Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, WI, USA; Cardiovascular Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Katherine R KulikDepartment of Cell Biology Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, WI, USA; Cardiovascular Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Michaela PattersonDepartment of Cell Biology Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, WI, USA; Cardiovascular Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
John W LoughDepartment of Cell Biology Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, WI, USA; Cardiovascular Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
John A AuchampachDepartment of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI, USA; Cardiovascular Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA. Electronic address: jauchamp@mcw.edu.
Medical College of Wisconsin · US

Funding

Genetic interactions and multifactorial genetics mediate myocardial regenerationR01HL155085 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI PATTERSON, MICHAELA · 2021 to 2025
$2.5M
Tip60, Ischemic Heart Disease and RegenerationR01HL131788 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI AUCHAMPACH, JOHN A, LOUGH, JOHN W · 2017 to 2020
$2.0M
VisualSonics Vevo 3100 High-Frequency Ultrasound Imaging SystemS10OD025038 · OD · MEDICAL COLLEGE OF WISCONSIN · PI AUCHAMPACH, JOHN A · 2019 to 2019
$302k
NHLBI NIH HHS R01 HL131788NHLBI NIH HHS R01 HL155085NIH HHS S10 OD025038
6 · The paper itself

Abstract

Injury from myocardial infarction (MI) and consequent post-MI remodeling is accompanied by massive loss of cardiomyocytes (CM), a cell type critical for contractile function that is for all practical purposes non-regenerable due to its profound state of proliferative senescence. Identification of factors that limit CM survival and/or constrain CM renewal provides potential therapeutic targets. Tip60, a pan-acetyltransferase encoded by the Kat5 gene, has been reported to activate apoptosis as well as multiple anti-proliferative pathways in non-cardiac cells; however, its role in CMs, wherein it is abundantly expressed, remains unknown. Here, using mice containing floxed Kat5 alleles and a tamoxifen-activated Myh6-MerCreMer recombinase transgene, we report that conditional depletion of Tip60 in CMs three days after MI induced by permanent coronary artery ligation greatly improves functional recovery for up to 28 days. This is accompanied by diminished scarring, activation of cell-cycle transit markers in CMs within the infarct border and remote zones, reduced expression of cell-cycle inhibitors pAtm and p27, and reduced apoptosis in the remote regions. These findings implicate Tip60 as a novel, multifactorial target for limiting the damaging effects of ischemic heart disease.

Indexed as

AcetyltransferasesMyocardial InfarctionAnimalsApoptosisCell CycleLysine Acetyltransferase 5MiceMyocytes, CardiacTrans-ActivatorsAcetyltransferasesKat5 protein, mouseLysine Acetyltransferase 5Trans-ActivatorsApoptosisCardiomyocyte proliferationCardioprotectionCell-cycleMyocardial infarctionRegenerationTip60

Identifiers

PMID34610340
PMCPMC8816866
OpenAlexW3203704329

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.